HEADER STRUCTURAL PROTEIN 01-JUL-08 3DMW TITLE CRYSTAL STRUCTURE OF HUMAN TYPE III COLLAGEN G982-G1023 CONTAINING C- TITLE 2 TERMINAL CYSTINE KNOT COMPND MOL_ID: 1; COMPND 2 MOLECULE: COLLAGEN ALPHA-1(III) CHAIN; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: UNP RESIDUES 1158-1199; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: CHEMICALLY SYNTHESIZED PEPTIDE G982-G1023 BASED ON SOURCE 4 THE FRAGMENT 1158-1199 OF THE HUMAN COLLAGEN ALPHA-1(III) CHAIN, SOURCE 5 CO3A1_HUMAN, UNIPROT ENTRY P02461. KEYWDS COLLAGEN III, CYSTINE KNOT, TRIPLE HELIX, GLYCINE, MAD PHASING, KEYWDS 2 ALTERNATIVE SPLICING, DISEASE MUTATION, EHLERS-DANLOS SYNDROME, KEYWDS 3 EXTRACELLULAR MATRIX, GLYCOPROTEIN, HYDROXYLATION, PHOSPHOPROTEIN, KEYWDS 4 POLYMORPHISM, SECRETED, STRUCTURAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.P.BOUDKO,J.ENGEL,K.OKUYAMA,K.MIZUNO,H.P.BACHINGER,M.A.SCHUMACHER REVDAT 4 20-OCT-21 3DMW 1 SEQADV LINK REVDAT 3 05-JAN-10 3DMW 1 JRNL REVDAT 2 24-FEB-09 3DMW 1 VERSN REVDAT 1 30-SEP-08 3DMW 0 JRNL AUTH S.P.BOUDKO,J.ENGEL,K.OKUYAMA,K.MIZUNO,H.P.BACHINGER, JRNL AUTH 2 M.A.SCHUMACHER JRNL TITL CRYSTAL STRUCTURE OF HUMAN TYPE III COLLAGEN GLY991-GLY1032 JRNL TITL 2 CYSTINE KNOT-CONTAINING PEPTIDE SHOWS BOTH 7/2 AND 10/3 JRNL TITL 3 TRIPLE HELICAL SYMMETRIES. JRNL REF J.BIOL.CHEM. V. 283 32580 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18805790 JRNL DOI 10.1074/JBC.M805394200 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.45 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 843794.430 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 89.6 REMARK 3 NUMBER OF REFLECTIONS : 3949 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.248 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.800 REMARK 3 FREE R VALUE TEST SET COUNT : 425 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.015 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 623 REMARK 3 BIN R VALUE (WORKING SET) : 0.3470 REMARK 3 BIN FREE R VALUE : 0.3470 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 52 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.048 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 740 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 61 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -9.64000 REMARK 3 B22 (A**2) : -7.59000 REMARK 3 B33 (A**2) : 17.24000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 15.88000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM SIGMAA (A) : 0.33 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.42 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.440 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 24.51 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP9.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN4.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3DMW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JUL-08. REMARK 100 THE DEPOSITION ID IS D_1000048236. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-DEC-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000, 0.979, 1.02, 0.97963 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 3964 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 34.450 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : 0.07500 REMARK 200 FOR THE DATA SET : 7.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.24000 REMARK 200 R SYM FOR SHELL (I) : 0.24000 REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 550, PH 7.0, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 10.76000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE PEPTIDE ASSEMBLES INTO A TRIPLE HELIX (3 CHAINS OF THE REMARK 300 42-MER) REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6600 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 PRO A 2 REMARK 465 CYS A 40 REMARK 465 GLY A 41 REMARK 465 GLY A 42 REMARK 465 GLY B 1 REMARK 465 PRO B 2 REMARK 465 ILE B 3 REMARK 465 GLY B 41 REMARK 465 GLY B 42 REMARK 465 GLY C 1 REMARK 465 CYS C 39 REMARK 465 CYS C 40 REMARK 465 GLY C 41 REMARK 465 GLY C 42 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY A 4 N - CA - C ANGL. DEV. = -18.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL DBREF 3DMW A 1 42 UNP P02461 CO3A1_HUMAN 1158 1199 DBREF 3DMW B 1 42 UNP P02461 CO3A1_HUMAN 1158 1199 DBREF 3DMW C 1 42 UNP P02461 CO3A1_HUMAN 1158 1199 SEQADV 3DMW MSE A 26 UNP P02461 GLN 1183 ENGINEERED MUTATION SEQADV 3DMW MSE B 26 UNP P02461 GLN 1183 ENGINEERED MUTATION SEQADV 3DMW MSE C 26 UNP P02461 GLN 1183 ENGINEERED MUTATION SEQRES 1 A 42 GLY PRO ILE GLY PRO HYP GLY PRO ARG GLY ASN ARG GLY SEQRES 2 A 42 GLU ARG GLY SER GLU GLY SER HYP GLY HIS HYP GLY MSE SEQRES 3 A 42 HYP GLY PRO HYP GLY PRO HYP GLY ALA HYP GLY PRO CYS SEQRES 4 A 42 CYS GLY GLY SEQRES 1 B 42 GLY PRO ILE GLY PRO HYP GLY PRO ARG GLY ASN ARG GLY SEQRES 2 B 42 GLU ARG GLY SER GLU GLY SER HYP GLY HIS HYP GLY MSE SEQRES 3 B 42 HYP GLY PRO HYP GLY PRO HYP GLY ALA HYP GLY PRO CYS SEQRES 4 B 42 CYS GLY GLY SEQRES 1 C 42 GLY PRO ILE GLY PRO HYP GLY PRO ARG GLY ASN ARG GLY SEQRES 2 C 42 GLU ARG GLY SER GLU GLY SER HYP GLY HIS HYP GLY MSE SEQRES 3 C 42 HYP GLY PRO HYP GLY PRO HYP GLY ALA HYP GLY PRO CYS SEQRES 4 C 42 CYS GLY GLY MODRES 3DMW HYP A 6 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP A 21 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP A 24 PRO 4-HYDROXYPROLINE MODRES 3DMW MSE A 26 MET SELENOMETHIONINE MODRES 3DMW HYP A 27 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP A 30 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP A 33 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP A 36 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP B 6 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP B 21 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP B 24 PRO 4-HYDROXYPROLINE MODRES 3DMW MSE B 26 MET SELENOMETHIONINE MODRES 3DMW HYP B 27 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP B 30 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP B 33 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP B 36 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP C 6 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP C 21 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP C 24 PRO 4-HYDROXYPROLINE MODRES 3DMW MSE C 26 MET SELENOMETHIONINE MODRES 3DMW HYP C 27 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP C 30 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP C 33 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP C 36 PRO 4-HYDROXYPROLINE HET HYP A 6 8 HET HYP A 21 8 HET HYP A 24 8 HET MSE A 26 8 HET HYP A 27 8 HET HYP A 30 8 HET HYP A 33 8 HET HYP A 36 8 HET HYP B 6 8 HET HYP B 21 8 HET HYP B 24 8 HET MSE B 26 8 HET HYP B 27 8 HET HYP B 30 8 HET HYP B 33 8 HET HYP B 36 8 HET HYP C 6 8 HET HYP C 21 8 HET HYP C 24 8 HET MSE C 26 8 HET HYP C 27 8 HET HYP C 30 8 HET HYP C 33 8 HET HYP C 36 8 HETNAM HYP 4-HYDROXYPROLINE HETNAM MSE SELENOMETHIONINE HETSYN HYP HYDROXYPROLINE FORMUL 1 HYP 21(C5 H9 N O3) FORMUL 1 MSE 3(C5 H11 N O2 SE) FORMUL 4 HOH *61(H2 O) SSBOND 1 CYS A 39 CYS B 40 1555 1555 2.04 LINK C PRO A 5 N HYP A 6 1555 1555 1.35 LINK C HYP A 6 N GLY A 7 1555 1555 1.33 LINK C SER A 20 N HYP A 21 1555 1555 1.34 LINK C HYP A 21 N GLY A 22 1555 1555 1.33 LINK C HIS A 23 N HYP A 24 1555 1555 1.34 LINK C HYP A 24 N GLY A 25 1555 1555 1.33 LINK C GLY A 25 N MSE A 26 1555 1555 1.33 LINK C MSE A 26 N HYP A 27 1555 1555 1.35 LINK C HYP A 27 N GLY A 28 1555 1555 1.33 LINK C PRO A 29 N HYP A 30 1555 1555 1.34 LINK C HYP A 30 N GLY A 31 1555 1555 1.33 LINK C PRO A 32 N HYP A 33 1555 1555 1.35 LINK C HYP A 33 N GLY A 34 1555 1555 1.33 LINK C ALA A 35 N HYP A 36 1555 1555 1.35 LINK C HYP A 36 N GLY A 37 1555 1555 1.33 LINK C PRO B 5 N HYP B 6 1555 1555 1.35 LINK C HYP B 6 N GLY B 7 1555 1555 1.33 LINK C SER B 20 N HYP B 21 1555 1555 1.35 LINK C HYP B 21 N GLY B 22 1555 1555 1.33 LINK C HIS B 23 N HYP B 24 1555 1555 1.34 LINK C HYP B 24 N GLY B 25 1555 1555 1.33 LINK C GLY B 25 N MSE B 26 1555 1555 1.33 LINK C MSE B 26 N HYP B 27 1555 1555 1.34 LINK C HYP B 27 N GLY B 28 1555 1555 1.33 LINK C PRO B 29 N HYP B 30 1555 1555 1.34 LINK C HYP B 30 N GLY B 31 1555 1555 1.33 LINK C PRO B 32 N HYP B 33 1555 1555 1.34 LINK C HYP B 33 N GLY B 34 1555 1555 1.33 LINK C ALA B 35 N HYP B 36 1555 1555 1.35 LINK C HYP B 36 N GLY B 37 1555 1555 1.33 LINK C PRO C 5 N HYP C 6 1555 1555 1.35 LINK C HYP C 6 N GLY C 7 1555 1555 1.33 LINK C SER C 20 N HYP C 21 1555 1555 1.34 LINK C HYP C 21 N GLY C 22 1555 1555 1.33 LINK C HIS C 23 N HYP C 24 1555 1555 1.34 LINK C HYP C 24 N GLY C 25 1555 1555 1.33 LINK C GLY C 25 N MSE C 26 1555 1555 1.33 LINK C MSE C 26 N HYP C 27 1555 1555 1.35 LINK C HYP C 27 N GLY C 28 1555 1555 1.33 LINK C PRO C 29 N HYP C 30 1555 1555 1.34 LINK C HYP C 30 N GLY C 31 1555 1555 1.33 LINK C PRO C 32 N HYP C 33 1555 1555 1.35 LINK C HYP C 33 N GLY C 34 1555 1555 1.33 LINK C ALA C 35 N HYP C 36 1555 1555 1.35 LINK C HYP C 36 N GLY C 37 1555 1555 1.33 CRYST1 31.980 21.520 68.970 90.00 92.58 90.00 P 1 21 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.031270 0.000000 0.001409 0.00000 SCALE2 0.000000 0.046468 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014514 0.00000